Literature DB >> 11035241

Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.

O Uzun1, S Arikan, S Kocagöz, B Sancak, S Unal.   

Abstract

Voriconazole is a promising azole effective against a variety of fungi, including yeasts. In this study, we tested in vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against some ATCC and reference strains and 250 clinical yeast isolates. We also evaluated the effect of time of reading on MIC results. Voriconazole was the most active agent against Candida and Trichosporon isolates, including the putatively fluconazole-resistant C. krusei (MIC(90) 0.25 microg/ml) and C. glabrata (MIC(90) 0.5 microg/ml). Amphotericin B MICs were scattered in a considerably narrow range in both RPMI 1640 and Antibiotic Medium 3. MICs at 24 hours and 48 hours were similar in general for all antifungals tested. The highest percentage of strains that showed 24-hour and 48-hour MICs within +/-1-log(2) dilution was observed for amphotericin B tested in RPMI (99%), and the lowest for amphotericin B tested in Antibiotic Medium 3 (80%). In conclusion, voriconazole is very effective against a wide spectrum of Candida species and 24-hour readings could substitute 48-hour MIC evaluation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035241     DOI: 10.1016/s0732-8893(00)00177-2

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  13 in total

1.  In vitro antifungal susceptibilities of Trichosporon species.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.

Authors:  Moan Shane Tsai; Yun Liang Yang; An Huei Wang; Lih Shinn Wang; Daniel C T Lu; Ci Hong Liou; Li Yun Hsieh; Chi Jung Wu; Ming Fang Cheng; Zhi Yuan Shi; Hsiu Jung Lo
Journal:  Mycopathologia       Date:  2012-02-09       Impact factor: 2.574

3.  Microbiological characteristics of medically important Trichosporon species.

Authors:  Hou-Min Li; Hong-Tao Du; Wei Liu; Zhe Wan; Ruo-Yu Li
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

4.  Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.

Authors:  Carolina Serena; Félix Gilgado; Marçal Mariné; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 5.  Update on the genus Trichosporon.

Authors:  Thomas C Chagas-Neto; Guilherme M Chaves; Arnaldo L Colombo
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

6.  Multidrug-resistant Trichosporon: an unusual fungal sepsis in preterm neonates.

Authors:  Sriparna Basu; Ragini Tilak; Ashok Kumar
Journal:  Pathog Glob Health       Date:  2015-06-03       Impact factor: 2.894

Review 7.  Current knowledge of Trichosporon spp. and Trichosporonosis.

Authors:  Arnaldo L Colombo; Ana Carolina B Padovan; Guilherme M Chaves
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

8.  Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.

Authors:  Thomas C Chagas-Neto; Guilherme M Chaves; Analy S A Melo; Arnaldo L Colombo
Journal:  J Clin Microbiol       Date:  2009-02-18       Impact factor: 5.948

9.  Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole.

Authors:  M C Serrano; D Morilla; A Valverde; M Chávez; A Espinel-Ingroff; R Claro; M Ramírez; E Martín Mazuelos
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

10.  Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.

Authors:  M Fleischhacker; C Radecke; B Schulz; M Ruhnke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.